ClinicalTrials.gov
ClinicalTrials.gov Menu

Prospective Study on a Novel Port-site Closure Device (EZ Close): Effectiveness and Comparison With Carter-Thomason

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03374189
Recruitment Status : Completed
First Posted : December 15, 2017
Last Update Posted : May 28, 2018
Sponsor:
Information provided by (Responsible Party):
Hee Youn Kim, Saint Vincent's Hospital, Korea

Brief Summary:
This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Condition or disease Intervention/treatment Phase
Surgical Port Site Hernia Device: EZ close Device: Carter Thomason Not Applicable

Detailed Description:
Port-site closure is a critical procedure after every laparoscopic surgery. Complications such as visceral organ injury, port-site hernia, infection, ascitic fluid leakage may occur during and after the procedure. Many devices were developed and utilized for the procedure and Carter-Thomason is one of the most commonly used device and validated with several studies. This study aims to evaluate the efficacy and safety of a novel port-site closure device (EZ Close) by comparing it with the Carter-Thomason device.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 79 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: Single Blind Randomized Control Trial Evaluating Efficacy and Safety of EZ-Close Port-site Closure Device Versus Carter-Thomason Device
Actual Study Start Date : August 17, 2017
Actual Primary Completion Date : May 9, 2018
Actual Study Completion Date : May 24, 2018

Arm Intervention/treatment
Experimental: EZ Close arm
EZ close used for port-site closure.
Device: EZ close
EZ close used.

Active Comparator: Carter Thomason arm
Carter Thomason used for port-site closure.
Device: Carter Thomason
Carter Thomason used.




Primary Outcome Measures :
  1. Time taken to complete closure [ Time Frame: At the time of surgery ]
    seconds


Secondary Outcome Measures :
  1. Visceral organ injury [ Time Frame: At the time of surgery ]
    Any inadvertent injury to organs or bleeding during procedure.

  2. Need for additional instrument [ Time Frame: At the time of surgery ]
    Need for additional instrument during procedure

  3. Port-site hernia [ Time Frame: Post-op and Within one months of surgery ]
    Herniation of bowel segments through port-site

  4. Port-site infection [ Time Frame: Post-op and Within one months of surgery ]
    Redness, purulent discharge, tenderness at port-site

  5. Ascitic fluid leakage [ Time Frame: Post-op and Within one months of surgery ]
    Non-infective fluid leakage

  6. Wound dehiscence [ Time Frame: Post-op and Within one months of surgery ]
    Wound dehiscence that required further treatment



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All patients with laparoscopic ports over 10mm

Exclusion Criteria:

  • Patients with laparoscopic ports under 10mm
  • Patients who refused the study
  • Patients who received concurrent surgery for other reason

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03374189


Locations
Korea, Republic of
St. Vincent's Hospital
Suwon, Korea, Republic of, 16247
Sponsors and Collaborators
Saint Vincent's Hospital, Korea
Investigators
Principal Investigator: Hee Youn Kim St. Vincent's Medical Center

Publications:
Responsible Party: Hee Youn Kim, Assistant Professor, Saint Vincent's Hospital, Korea
ClinicalTrials.gov Identifier: NCT03374189     History of Changes
Other Study ID Numbers: EZVSCT
First Posted: December 15, 2017    Key Record Dates
Last Update Posted: May 28, 2018
Last Verified: May 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No